Core Viewpoint - McKesson reported quarterly earnings of $8.26 per share, exceeding the Zacks Consensus Estimate of $8.23 per share, and showing an increase from $7.88 per share a year ago, indicating a positive earnings surprise of +0.36% [1][2] Financial Performance - The company achieved revenues of $97.83 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.82%, and up from $79.28 billion in the same quarter last year [2] - Over the last four quarters, McKesson has exceeded consensus EPS estimates three times and topped revenue estimates two times [2] Stock Performance - McKesson shares have increased approximately 24.5% since the beginning of the year, significantly outperforming the S&P 500's gain of 7.1% [3] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $8.61 for the coming quarter and $37.26 for the current fiscal year, alongside projected revenues of $103.81 billion and $406.16 billion respectively [7] - The Zacks Rank for McKesson is currently 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] Industry Context - The Medical - Dental Supplies industry, to which McKesson belongs, is currently in the top 25% of over 250 Zacks industries, suggesting a favorable environment for stock performance [8]

Core Viewpoint - Blackbaud (BLKB) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of earnings estimate revisions, which have shown a strong correlation with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in stock price movements [4]. Blackbaud's Earnings Outlook - Blackbaud is projected to earn $4.40 per share for the fiscal year ending December 2025, with no year-over-year change expected [8]. - Over the past three months, the Zacks Consensus Estimate for Blackbaud has increased by 1.8%, reflecting a positive outlook for the company's earnings [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with only the top 20% of stocks receiving a "Strong Buy" or "Buy" rating [9][10]. - Blackbaud's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [10].

Group 1 - Novavax reported quarterly earnings of $0.62 per share, exceeding the Zacks Consensus Estimate of a loss of $0.07 per share, representing an earnings surprise of +985.71% [1] - The company posted revenues of $239.24 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 102.74%, compared to year-ago revenues of $415.48 million [2] - Novavax has consistently surpassed consensus EPS estimates over the last four quarters [2] Group 2 - The stock has underperformed the market, losing about 16.3% since the beginning of the year, while the S&P 500 has gained 7.1% [3] - The company's earnings outlook will be crucial for future stock performance, with current consensus EPS estimates at -$0.22 for the coming quarter and $2.54 for the current fiscal year [4][7] - The Zacks Industry Rank indicates that the Medical - Biomedical and Genetics sector is currently in the bottom 42% of over 250 Zacks industries, which may impact stock performance [8]

Company Performance - Holley Inc. reported quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.10 per share, and down from $0.10 per share a year ago, representing an earnings surprise of -10.00% [1] - The company posted revenues of $166.66 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.53%, but down from $169.5 million year-over-year [2] - Over the last four quarters, Holley has surpassed consensus EPS estimates just once and topped consensus revenue estimates three times [2] Stock Performance - Holley shares have lost approximately 32.5% since the beginning of the year, contrasting with the S&P 500's gain of 7.1% [3] - The current consensus EPS estimate for the coming quarter is $0.03 on revenues of $134.7 million, and for the current fiscal year, it is $0.20 on revenues of $591.48 million [7] Industry Outlook - The Automotive - Original Equipment industry, to which Holley belongs, is currently in the top 35% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that industry performance can significantly impact stock performance [5][8]

Company Performance - Telesat reported quarterly earnings of $1 per share, significantly beating the Zacks Consensus Estimate of a loss of $0.69 per share, and showing improvement from a loss of $2.87 per share a year ago, resulting in an earnings surprise of +244.93% [1] - The company posted revenues of $76.69 million for the quarter ended June 2025, which missed the Zacks Consensus Estimate by 2.99% and decreased from year-ago revenues of $111.41 million [2] - Over the last four quarters, Telesat has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times as well [2] Stock Performance - Telesat shares have increased approximately 47.1% since the beginning of the year, outperforming the S&P 500's gain of 7.1% [3] - The stock's immediate price movement will depend on management's commentary during the earnings call and future earnings expectations [3][4] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$1.11 on revenues of $65.31 million, and for the current fiscal year, it is -$2.29 on revenues of $298.96 million [7] - The estimate revisions trend for Telesat was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Satellite and Communication industry, to which Telesat belongs, is currently ranked in the bottom 33% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which investors can track [5]

Core Insights - Kornit Digital (KRNT) reported quarterly earnings of $0.03 per share, exceeding the Zacks Consensus Estimate of $0.02 per share, and showing an increase from $0.02 per share a year ago, resulting in an earnings surprise of +50.00% [1] - The company posted revenues of $49.75 million for the quarter ended June 2025, which was 4.35% below the Zacks Consensus Estimate, but an increase from $48.62 million year-over-year [2] - Kornit Digital has surpassed consensus EPS estimates three times over the last four quarters, while also topping revenue estimates three times in the same period [2] Earnings Outlook - The future performance of Kornit Digital's stock will largely depend on management's commentary during the earnings call and the sustainability of the stock's immediate price movement based on the recently released numbers [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.09 on revenues of $57.34 million, and for the current fiscal year, it is $0.31 on revenues of $222.46 million [7] Industry Context - The Commercial Printing industry, to which Kornit Digital belongs, is currently ranked in the top 13% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Company Performance - Middleby (MIDD) reported quarterly earnings of $2.35 per share, exceeding the Zacks Consensus Estimate of $2.20 per share, but down from $2.39 per share a year ago, representing an earnings surprise of +6.82% [1] - The company posted revenues of $977.86 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.31%, but down from $991.55 million year-over-year [2] - Over the last four quarters, Middleby has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] Stock Outlook - Middleby shares have increased approximately 6.8% since the beginning of the year, compared to the S&P 500's gain of 7.1% [3] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for investors [4] - The current consensus EPS estimate for the coming quarter is $2.24 on revenues of $971.84 million, and for the current fiscal year, it is $9.19 on revenues of $3.89 billion [7] Industry Context - The Manufacturing - General Industrial industry, to which Middleby belongs, is currently ranked in the top 16% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Middleby's stock performance [5]

Company Performance - Arvinas, Inc. reported a quarterly loss of $0.84 per share, which was better than the Zacks Consensus Estimate of a loss of $0.87, but worse than a loss of $0.49 per share a year ago, indicating an earnings surprise of +3.45% [1] - The company posted revenues of $22.4 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 53.28%, and a significant decline from year-ago revenues of $76.5 million [2] - Over the last four quarters, Arvinas has surpassed consensus EPS estimates four times and topped consensus revenue estimates two times [2] Stock Outlook - Arvinas shares have declined approximately 60.3% since the beginning of the year, contrasting with the S&P 500's gain of 7.1% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is -$0.75 on revenues of $41.04 million, and for the current fiscal year, it is -$1.50 on revenues of $294.99 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Arvinas belongs, is currently ranked in the bottom 42% of over 250 Zacks industries, suggesting that the industry outlook may negatively impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors or through tools like the Zacks Rank [5][6]

MarketAxess, which belongs to the Zacks Financial - Investment Bank industry, posted revenues of $219.46 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.59%. This compares to year-ago revenues of $197.66 million. The company has topped consensus revenue estimates two times over the last four quarters. MarketAxess (MKTX) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.94 per share. This compares to earnings of $1.72 per share ...

Company Performance - DNOW reported quarterly earnings of $0.27 per share, exceeding the Zacks Consensus Estimate of $0.22 per share, and showing an increase from $0.25 per share a year ago, representing an earnings surprise of +22.73% [1] - The company posted revenues of $628 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.19%, although this is a slight decrease from year-ago revenues of $633 million [2] - DNOW has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Stock Performance - DNOW shares have increased approximately 17.1% since the beginning of the year, compared to a 7.1% gain in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $0.22 on revenues of $618.25 million, and for the current fiscal year, it is $0.86 on revenues of $2.42 billion [7] Industry Outlook - The Manufacturing - General Industrial industry, to which DNOW belongs, is currently ranked in the top 16% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact DNOW's stock performance [5]